MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AUTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Autolus Therapeutics (AUTL) Ownership - Who owns Autolus Therapeutics?

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
752
Web
https://www.autolus.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
407.2M
P/E Ratio
N/A
Total Cash
229.43M
Projected Growth
N/A
Total Debt
79.96M
Revenue
92.62M
Risk (Beta)
2.79
Dividend Yield
N/A
Total Cash/Share
0.86
Total Debt/Equity
N/A
Revenue/Share
0.35 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AUTL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for AUTL
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
752
Web
https://www.autolus.com